Shandong Kexing bioproducts Co., Ltd

Product Information

• Indication:Granulocytopenia resulting from chemotherapy For cancer patients taking bone marrow suppression drugs, especially after the treatment with some strong bone marrow deprivation chemical drugs, the in
• Specification:75ug, 150ug,300ug
• Dosage Form:Injection
• Active Ingredients:Recombinant human granulocyte colony-stimulating factor
• Route of Administration:Subcutaneous Injection
• Shelf Life:2 years
• Storage:2℃-8℃
• Package:1 vial/ syringe
• Place of Origin:China
• Qualification:Chinese GMP

Description